Yellow fever-associated viscerotropic disease in Barcelona, Spain

J Travel Med. 2008 May-Jun;15(3):202-5. doi: 10.1111/j.1708-8305.2008.00209.x.

Abstract

Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.

Publication types

  • Review

MeSH terms

  • Adult
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Organ Failure / etiology*
  • Multiple Organ Failure / immunology
  • Multiple Organ Failure / therapy
  • Respiratory Distress Syndrome / etiology
  • Risk Factors
  • Spain
  • Systemic Inflammatory Response Syndrome / etiology
  • Treatment Outcome
  • Vaccines, Attenuated / adverse effects
  • Yellow Fever / immunology
  • Yellow Fever / prevention & control*
  • Yellow Fever Vaccine / administration & dosage
  • Yellow Fever Vaccine / adverse effects*

Substances

  • Vaccines, Attenuated
  • Yellow Fever Vaccine